INCIDENCE OF REACTIONS FOLLOWING ADMINISTRATION OF ANTIRABIES SERUM; STUDY OF 526 CASES.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone; D000375:Aging; D002648:Child; D003888:Desensitization, Immunologic; D004358:Drug Therapy; D006634:Histamine H1 Antagonists; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D011818:Rabies; D011819:Rabies Vaccines; D012713:Serum Sickness; D012877:Skin Manifestations; D013223:Statistics as Topic; D014481:United States; D014944:World Health Organization
D006634:Histamine H1 Antagonists; D007106:Immune Sera; D011819:Rabies Vaccines; D000324:Adrenocorticotropic Hormone
ADOLESCENCE; AGING; ANTIHISTAMINICS; CHILD; CORTICOTROPIN; DESENSITIZATION; DRUG THERAPY; IMMUNE SERUMS; INFANT; INFANT, NEWBORN; RABIES; SEROTHERAPY; SERUM SICKNESS; SKIN MANIFESTATIONS; STATISTICS; UNITED STATES; WORLD HEALTH ORGANIZATION